Aug 08, 2013, 01.38 PM IST
TPG Capital LP has been exploring a sale of Aptalis Pharma, a specialty drugmaker it has owned since 2008 and values at more than USD 3 billion, four people familiar with the matter said on Wednesday.
Like this story, share it with millions of investors on M3
TPG explores $3 bn sale of specialty drugmaker Aptalis
TPG Capital LP has been exploring a sale of Aptalis Pharma, a specialty drugmaker it has owned since 2008 and values at more than USD 3 billion, four people familiar with the matter said on Wednesday.
Like this story, share it with millions of investors on M3
TPG explores $3 bn sale of specialty drugmaker Aptalis
TPG Capital LP has been exploring a sale of Aptalis Pharma, a specialty drugmaker it has owned since 2008 and values at more than USD 3 billion, four people familiar with the matter said on Wednesday.
Anda sedang membaca artikel tentang
TPG explores $3 bn sale of specialty drugmaker Aptalis
Dengan url
https://kesehatanda.blogspot.com/2013/08/tpg-explores-3-bn-sale-of-specialty.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
TPG explores $3 bn sale of specialty drugmaker Aptalis
namun jangan lupa untuk meletakkan link
TPG explores $3 bn sale of specialty drugmaker Aptalis
sebagai sumbernya
0 komentar:
Posting Komentar